Nath Bio-Genes (India) Limited vs Nestle India Limited
A side-by-side comparison of Nath Bio-Genes (India) Limited (NATHBIOGEN) and Nestle India Limited (NESTLEIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Nath Bio-Genes (India) Limited leads NATHBIOGEN vs NESTLEIND on 7 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation40
- Profitability03
- Growth20
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
NATHBIOGEN takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
NESTLEIND takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
NATHBIOGEN takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
NESTLEIND takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Stock is trading at 0.38 times its book value"]
- − ["The company has delivered a poor sales growth of 7.7% over past five years.", "The company has delivered a poor profit growth of -5.6% over past five years.", "Company has a low return on equity of 6.4% over last 3 years."]
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 94.0%", "Company has been maintaining a healthy dividend payout of 77.2%"]
- − ["Stock is trading at 47.32 times its book value"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.